(Q35205214)

7 August 2017

Emerging science of the human microbiome (English)

1 reference

7 August 2017

0 references

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25013912%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

author name string

Mitchell L Jones

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25013912%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Jorge G Ganopolsky

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25013912%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Christopher J Martoni

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25013912%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Alain Labbé

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25013912%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

publication date

11 July 2014

1 reference

7 August 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25013912%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

volume

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25013912%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25013912%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

page(s)

446-457

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25013912%20AND%20SRC:MED&resulttype=core&format=json

An estimation of the number of cells in the human body

11 June 2020

cites work

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.29810

Prokaryotes: the unseen majority

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.29810

Host-bacterial mutualism in the human intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.29810

Ecological and evolutionary forces shaping microbial diversity in the human intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.29810

The human microbiome project

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.29810

Measurement of in situ activities of nonphotosynthetic microorganisms in aquatic and terrestrial habitats

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.29810

A renaissance for the pioneering 16S rRNA gene

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.29810

The gut flora as a forgotten organ

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.29810

Polysaccharide utilization by gut bacteria: potential for new insights from genomic analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.29810

Glycan foraging in vivo by an intestine-adapted bacterial symbiont

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.29810

Bacteria as vitamin suppliers to their host: a gut microbiota perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.29810

Effects of probiotics and commensals on intestinal epithelial physiology: implications for nutrient handling

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.29810

Identifying genetic determinants needed to establish a human gut symbiont in its habitat

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.29810

ComPPARtmentalizing NF-kappaB in the gut.

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.29810

Role of the commensal microbiota in normal and pathogenic host immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.29810

Host-microbe interactions that facilitate gut colonization by commensal bifidobacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.29810

Probiotics, prebiotics and immunomodulation of gut mucosal defences: homeostasis and immunopathology

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.29810

A Genomic View of the Human-Bacteroides thetaiotaomicron Symbiosis

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.29810

Bacterial colonization factors control specificity and stability of the gut microbiota

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.29810

Adaptation of colonic fermentation and glucagon-like peptide-1 secretion with increased wheat fibre intake for 1 year in hyperinsulinaemic human subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.29810

Microbial modulation of energy availability in the colon regulates intestinal transit

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.29810

Commensal bacteria at the interface of host metabolism and the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.29810

Short-chain fatty acids act as antiinflammatory mediators by regulating prostaglandin E(2) and cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.29810

Functional characterization of human receptors for short chain fatty acids and their role in polymorphonuclear cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.29810

Autophagy and intestinal homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.29810

The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.29810

Role of bile acids and bile acid receptors in metabolic regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.29810

The interaction between bacteria and bile.

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.29810

Pleiotropic roles of bile acids in metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.29810

Systemic gut microbial modulation of bile acid metabolism in host tissue compartments

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.29810

Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.29810

Activation of the nuclear receptor FXR improves hyperglycemia and hyperlipidemia in diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.29810

Role of fibroblast growth factor 19 in the control of glucose homeostasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.29810

FXR signaling in the enterohepatic system

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.29810

The G-protein-coupled bile acid receptor, Gpbar1 (TGR5), negatively regulates hepatic inflammatory response through antagonizing nuclear factor κ light-chain enhancer of activated B cells (NF-κB) in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.29810

Targeted disruption of G protein-coupled bile acid receptor 1 (Gpbar1/M-Bar) in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.29810

Bile acids promote glucagon-like peptide-1 secretion through TGR5 in a murine enteroendocrine cell line STC-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.29810

TGR5-mediated bile acid sensing controls glucose homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.29810

Hydrophobic bile salts inhibit gallbladder smooth muscle function via stimulation of GPBAR1 receptors and activation of KATP channels.

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.29810

The G protein-coupled bile acid receptor, TGR5, stimulates gallbladder filling

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.29810

Targeted deletion of Gpbar1 protects mice from cholesterol gallstone formation

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.29810

The impact of the gut microbiota on human health: an integrative view

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.29810

The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.29810

Genetically dictated change in host mucus carbohydrate landscape exerts a diet-dependent effect on the gut microbiota

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.29810

Enterotypes of the human gut microbiome

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.29810

The long-term stability of the human gut microbiota

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.29810

Bacterial community variation in human body habitats across space and time

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.29810

Temporal stability analysis of the microbiota in human feces by denaturing gradient gel electrophoresis using universal and group-specific 16S rRNA gene primers

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.29810

Succession of microbial consortia in the developing infant gut microbiome

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.29810

Meconium microbiota types dominated by lactic acid or enteric bacteria are differentially associated with maternal eczema and respiratory problems in infants

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.29810

Bacterial diversity in meconium of preterm neonates and evolution of their fecal microbiota during the first month of life

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.29810

Diversified microbiota of meconium is affected by maternal diabetes status

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.29810

Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.29810

Development of the human infant intestinal microbiota

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.29810

Composition, variability, and temporal stability of the intestinal microbiota of the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.29810

Human susceptibility and resistance to Norwalk virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.29810

Campylobacter jejuni binds intestinal H(O) antigen (Fuc alpha 1, 2Gal beta 1, 4GlcNAc), and fucosyloligosaccharides of human milk inhibit its binding and infection

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.29810

Inflammation-associated enterotypes, host genotype, cage and inter-individual effects drive gut microbiota variation in common laboratory mice

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.29810

Organismal, genetic, and transcriptional variation in the deeply sequenced gut microbiomes of identical twins

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.29810

Gut microbiota from twins discordant for obesity modulate metabolism in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.29810

Microbial ecology: human gut microbes associated with obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.29810

Predicting a human gut microbiota's response to diet in gnotobiotic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.29810

Characterizing a model human gut microbiota composed of members of its two dominant bacterial phyla

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.29810

A humanized gnotobiotic mouse model of host-archaeal-bacterial mutualism

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.29810

Diet rapidly and reproducibly alters the human gut microbiome

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.29810

Selective stimulation of bifidobacteria in the human colon by oligofructose and inulin

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.29810

A double-blind, placebo-controlled, cross-over study to establish the bifidogenic effect of a very-long-chain inulin extracted from globe artichoke (Cynara scolymus) in healthy human subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.29810

Impact of a resistant dextrin on intestinal ecology: how altering the digestive ecosystem with NUTRIOSE®, a soluble fibre with prebiotic properties, may be beneficial for health.

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.29810

Prebiotic effect of fruit and vegetable shots containing Jerusalem artichoke inulin: a human intervention study

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.29810

Mechanisms and effectiveness of prebiotics in modifying the gastrointestinal microbiota for the management of digestive disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.29810

Linking long-term dietary patterns with gut microbial enterotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.29810

Metagenome-wide analysis of antibiotic resistance genes in a large cohort of human gut microbiota

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.29810

Microbiota-liberated host sugars facilitate post-antibiotic expansion of enteric pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.29810

What are the consequences of the disappearing human microbiota?

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.29810

Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.29810

Toll-like receptors' pathway disturbances are associated with increased susceptibility to infections in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.29810

Compartmentalized and systemic control of tissue immunity by commensals

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.29810

The role of the immune system in governing host-microbe interactions in the intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.29810

Innate immune recognition of the microbiota promotes host-microbial symbiosis

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.29810

Control of pathogens and pathobionts by the gut microbiota

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.29810

Genomic approaches to studying the human microbiota

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.29810

Diet-induced dysbiosis of the intestinal microbiota and the effects on immunity and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.29810

Symptomatic atherosclerosis is associated with an altered gut metagenome

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.29810

A metagenome-wide association study of gut microbiota in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.29810

Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.29810

Richness of human gut microbiome correlates with metabolic markers

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.29810

Functional and comparative metagenomic analysis of bile salt hydrolase activity in the human gut microbiome.

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.29810

A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.29810

The effect of infections on susceptibility to autoimmune and allergic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.29810

Dietary intervention impact on gut microbial gene richness

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.29810

A human gut microbial gene catalogue established by metagenomic sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.29810

Twin study indicates loss of interaction between microbiota and mucosa of patients with ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.29810

Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.29810

Antibiotics in early life alter the murine colonic microbiome and adiposity

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.29810

Probiotics: properties, examples, and specific applications.

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.29810

An update on the use and investigation of probiotics in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.29810

Probiotics in the management of irritable bowel syndrome and inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.29810

The gut microbiota as an environmental factor that regulates fat storage

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.29810

Connecting dysbiosis, bile-acid dysmetabolism and gut inflammation in inflammatory bowel diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.29810

Increase in fecal primary bile acids and dysbiosis in patients with diarrhea-predominant irritable bowel syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.29810

Dysbiosis modulates capacity for bile acid modification in the gut microbiomes of patients with inflammatory bowel disease: a mechanism and marker of disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.29810

Effect of dietary inulin supplementation on inflammation of pouch mucosa in patients with an ileal pouch-anal anastomosis

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.29810

The effect on the blood lipid profile of soy foods combined with a prebiotic: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.29810

A double-blind, placebo-controlled, randomized human study assessing the capacity of a novel galacto-oligosaccharide mixture in reducing travellers' diarrhoea

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.29810

Clinical trial: the effects of a trans-galactooligosaccharide prebiotic on faecal microbiota and symptoms in irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.29810

High-fiber diet supplementation in patients with irritable bowel syndrome (IBS): a multicenter, randomized, open trial comparison between wheat bran diet and partially hydrolyzed guar gum (PHGG).

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.29810

Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.29810

Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.29810

Intestinal microbiota in patients with nonalcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.29810

Fecal Microbiome and Volatile Organic Compound Metabolome in Obese Humans With Nonalcoholic Fatty Liver Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.29810

Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.29810

Glycerol induces reuterin production and decreases Escherichia coli population in an in vitro model of colonic fermentation with immobilized human feces

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.29810

Letter to the editor regarding the report of Duboc et al: Connecting dysbiosis, bile-acid dysmetabolism and gut inflammation in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.29810

Oral supplementation with probiotic L. reuteri NCIMB 30242 increases mean circulating 25-hydroxyvitamin D: a post hoc analysis of a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.29810

Probiotics in the prevention of antibiotic-associated diarrhea in children: a meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.29810

Meta-analysis of probiotics for the prevention of antibiotic associated diarrhea and the treatment of Clostridium difficile disease

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.29810

Use of probiotic Lactobacillus preparation to prevent diarrhoea associated with antibiotics: randomised double blind placebo controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.29810

Probiotics for prevention and treatment of diarrhea.

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.29810

Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.29810

Treatment of relapsing mild-to-moderate ulcerative colitis with the probiotic VSL#3 as adjunctive to a standard pharmaceutical treatment: a double-blind, randomized, placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.29810

Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.29810

VSL#3 probiotic modifies mucosal microbial composition but does not reduce colitis-associated colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.29810

Gut microbiota disturbance during antibiotic therapy: a multi-omic approach

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.29810